Retinal Vasculitis Secondary to Durvalumab

Retinal Vasculitis Secondary to Durvalumab

Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, t...

Full description

Bibliographic Details
Main Authors: Antonio R. Andrade, Aina Moll-Udina, Ruth Martin, Esther Cilveti, Olaia Subirà, Laura Disfetano, Jose García-Arumí
Format: Article
Language:English
Published: Karger Publishers 2020-05-01
Series:Case Reports in Ophthalmology
Subjects:
vasculitis
retina
checkpoint inhibitors
cancer therapy
durvalumab
Online Access:https://www.karger.com/Article/FullText/507609

Internet

https://www.karger.com/Article/FullText/507609

Similar Items